Table 6.
B cell epitope prediction for receptor binding domain (RBD)- 333 to 527 | |||||
---|---|---|---|---|---|
Method of prediction | Sl no. | Start point | End point | Peptide sequence | Length of peptide |
Kolaskar and Tangaonkar antigenicity | 1 | 336 | 341 | CPFGEV | 6 |
2 | 347 | 353 | FASVYAW | 7 | |
3 | 358 | 372 | ISNCVADYSVLYNSA | 15 | |
4 | 374 | 385 | FSTFKCYGVSPT | 12 | |
5 | 387 | 404 | LNDLCFTNVYADSFVIRG | 18 | |
6 | 407 | 412 | VRQIAP | 6 | |
7 | 429 | 436 | FTGCVIAW | 8 | |
8 | 450 | 456 | NYLYRLF | 7 | |
9 | 470 | 478 | TEIYQAGST | 9 | |
10 | 485 | 497 | GFNCYFPLQSYGF | 13 | |
Emini Surface Accessibility Prediction | 1 | 419 | 428 | ADYNYKLPDD | 10 |
2 | 437 | 442 | NSNNLD | 6 | |
3 | 455 | 468 | LFRKSNLKPFERDI | 14 | |
4 | 495 | 500 | YGFQPT | 6 | |
Bepipred Linear Epitope Prediction | 1 | 382 | 385 | VSPT | 4 |
2 | 407 | 420 | VRQIAPGQTGKIAD | 14 | |
3 | 423 | 428 | YKLPDD | 6 | |
4 | 439 | 447 | NNLDSKVGG | 9 | |
5 | 461 | 463 | LKP | 3 | |
6 | 466 | 467 | RD | 2 | |
7 | 469 | 469 | S | 1 | |
8 | 473 | 483 | YQAGSTPCNGV | 11 | |
9 | 495 | 506 | YGFQPTNGVGYQ | 12 |